Navigation Links
Tosedostat OPAL Study in Acute Myeloid Leukemia Published in Lancet Oncology
Date:3/4/2013

  • Overall response rate (ORR) of 22% (16/73), with 10% (7/73) achieving a complete response (CR) and 29% (21/73) of patients achieving stable disease (SD) for a disease control rate of 51%.
  • High response rates were observed in patients who previously received HMAs or initially were diagnosed with MDS, with an ORR of 38% (10/26) and 37% (7/19), respectively.
  • Median overall survival (OS) for patients achieving a CR was 322 days; partial response (PR) 195 days; and SD 162 days.
  • Adverse events were similar between dosing groups. Tosedostat was generally well-tolerated, with the majority of adverse events of grade 1 and 2. The most common treatment-related serious adverse event was febrile neutropenia reported in 29% of patients. 

"There are limited therapeutic options available for elderly patients who, after failing hypomethylating therapy, experience AML progression from MDS," said Dr. Cortes. "The novel mechanism of action and observed response rate in this completed Phase 2 study suggests that tosedostat could address this unmet medical need. We are currently conducting a Phase 2 study investigating the combination of tosedostat with azacytidine - an HMA, or low-dose cytarabine, a standard leukemia therapy in patients with relapsed or refractory AML and MDS - to determine if tosedostat would be safe and more effective when used in combination with these agents." 

The publication by Dr. Cortes, et al. titled "Two dosing regimens of tosedostat in elderly patients with relapsed or refractory acute myeloid leukemia (OPAL): a randomized open-label phase 2 study," is available at http://www.thelancet.com/journals/lanonc/issue/current.

About Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

About 13,780 new cases of AML were expected to be diagnosed in the Un
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Longitudinal Study Highlights Evolving Role of Medical Science Liaisons with Thought Leaders and Product Development
2. New Study Shows Cannabis Effects on Driving Skills
3. Independent Study Published in Clinical Infectious Diseases Highlights the Importance of Antimicrobial Removal Systems in Blood Culture to Rapidly and Accurately Aid in the Diagnosis of Sepsis
4. University Hospitals Case Medical Center Presents Study On The Elimination Of Retained Surgical Sponges
5. MD+DI, the Global MedTech Authority, Publishes One-of-a-Kind Study with ITG Market Research on the Medical Device Outsourcing Landscape
6. New Direct-to-Consumer Prescription Delivery Channel Mitigates Risk of Medication Non-Adherence Highlighted in JAMA Internal Medicine Study
7. KaloBios Presents Clinical Results with Anti-GM-CSF Antibody in Persistent Asthma Data from KB002 Phase 1/2 Study Presented at the American Academy of Allergy, Asthma and Immunology Meeting
8. Study Shows Medicare Savings When Local Pharmacies Fill 90-Day Prescriptions
9. Isis Pharmaceuticals Initiates Phase 2 Study Of ISIS-CRP Rx In Patients With Atrial Fibrillation
10. Adynxx Enrolls First Patient in Phase 2 Proof-of-Concept Study for AYX1, Lead Compound for the Prevention of Post-Surgical Pain
11. First U.S. Patients Treated in PneumRx RENEW Pivotal Study for Treatment of Severe Emphysema
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... April 24, 2015 Boston Scientific Corporation (NYSE: ... 40 th Annual Healthcare Conference on May 6 in ... , executive vice president and chief financial officer, and ... a 35-minute question and answer session regarding the company with ... A live webcast of the presentation and question and answer ...
(Date:4/24/2015)... , April 24, 2015 The National ... of the National Institutes of Health [NIH])  provided ... research projects for the development of diagnostic tests ... HAI outbreaks at U.S. health facilities , the ... into rapid, multiplexed and effective tests using alternative ...
(Date:4/24/2015)... , April 24, 2015  Elekta has CE marked ... treatment planning system , enabling European clinics to deliver ... treatment techniques including advanced 3D planning, IMRT, VMAT and ... Monaco ® ... improved workflow efficiency. Advancements in 3D planning as well ...
Breaking Medicine Technology:Boston Scientific To Participate In The Deutsche Bank 40th Annual Healthcare Conference 2Kalorama: NIAID Rewards HAI Innovators with Grants 2Kalorama: NIAID Rewards HAI Innovators with Grants 3Kalorama: NIAID Rewards HAI Innovators with Grants 4Elekta CE marks for Monaco v5.10 treatment planning system 2
... Phase III monotherapy study shows ACTEMRA is first and only biologic ... ... treatment -, PARIS, ... rheumatoid arthritis (RA) -- despite treatment with,current therapies -- achieved significant ...
... NicOx S.A. (Euronext Paris: COX) today announced an ... 301 phase 3 study, showing a,statistically significant difference ... change from baseline in systolic and diastolic blood,pressure ... 4 comparisons). Commonly used,Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), such ...
Cached Medicine Technology:ACTEMRA(R) (tocilizumab) Significantly Reduces Rheumatoid Arthritis Signs and Symptoms Regardless of Previous Therapy in Two New Global Studies 2ACTEMRA(R) (tocilizumab) Significantly Reduces Rheumatoid Arthritis Signs and Symptoms Regardless of Previous Therapy in Two New Global Studies 3ACTEMRA(R) (tocilizumab) Significantly Reduces Rheumatoid Arthritis Signs and Symptoms Regardless of Previous Therapy in Two New Global Studies 4ACTEMRA(R) (tocilizumab) Significantly Reduces Rheumatoid Arthritis Signs and Symptoms Regardless of Previous Therapy in Two New Global Studies 5ACTEMRA(R) (tocilizumab) Significantly Reduces Rheumatoid Arthritis Signs and Symptoms Regardless of Previous Therapy in Two New Global Studies 6ACTEMRA(R) (tocilizumab) Significantly Reduces Rheumatoid Arthritis Signs and Symptoms Regardless of Previous Therapy in Two New Global Studies 7NicOx Announces Blood Pressure Analysis From 301 Phase 3 Study for Naproxcinod at EULAR 2NicOx Announces Blood Pressure Analysis From 301 Phase 3 Study for Naproxcinod at EULAR 3NicOx Announces Blood Pressure Analysis From 301 Phase 3 Study for Naproxcinod at EULAR 4
(Date:4/26/2015)... (PRWEB) April 26, 2015 A ... 2015 in the U.S. District Court, Northern District ... ( http://www.testosteronelawsuithub.com/ ) have been consolidated for ... court documents, matters addressed included the intention of ... claims involving their products on preemption grounds, with ...
(Date:4/26/2015)... Compare-autoinsurance.org has released a new blog post explaining how to ... way to find low cost auto insurance is by comparing ... online, in a simple and convenient way. It is no ... insurance prices. All the details are now freely available to ... now possible to compare online car insurance quotes on a ...
(Date:4/26/2015)... 26, 2015 With the FCPX LUT B&W ... editors can quickly and easily add desaturated color grades ... a mathematical formula for modifying an image. The LUT changes ... table. This pack comes with 60 black and white CUBE ... contemporary black and white films. With the FCPX LUT ...
(Date:4/26/2015)... 2015 A live auction will be ... from hospitals, surgery centers and other medical facilities around ... sold including radiology, surgery, endoscopy, lab, anesthesia, exam and ... place Tuesday, April 28th starting at 10:00am EDT. The ... 5025 North Hiatus Rd., Sunrise, FL 33351. Anyone ...
(Date:4/26/2015)... (PRWEB) April 26, 2015 This annual ... of the season and will include a spectacular collection ... totes, collectibles, herbal soaps and incense, chimes, vases, candleholders, ... this year’s exciting and unique collection of vendors, guests ... with Jim Martocci and the Jimmie Jazz Band. ...
Breaking Medicine News(10 mins):Health News:Court Overseeing Federal Testosterone Treatment Lawsuits Convenes April Case Management Conference 2Health News:Court Overseeing Federal Testosterone Treatment Lawsuits Convenes April Case Management Conference 3Health News:Court Overseeing Federal Testosterone Treatment Lawsuits Convenes April Case Management Conference 4Health News:Finding Low Cost Auto Insurance - An Online Guide Provides Tips 2Health News:Pixel Film Studios, a FCPX Effects Developer, Announced the Release of FCPX LUT B&W 2Health News:Centurion Service Group to Auction off 1,200 Lots of Medical Equipment 2Health News:It’s Coming! The 5th Annual Tulip Festival & Mother’s Day Celebration at Honor's Haven Resort & Spa! 2
... ... BCS Global and Polycom help customers transform their business, improve collaboration, enhance productivity ... ... Limited ( www.bcsglobal.com ), a leading worldwide managed service provider of videoconferencing and ...
... survey released today reveals that just 12 percent of ... spoken to their child,s doctor about complementary and integrative ... want to know more. The survey, conducted by ... attitudes about various approaches to treating a child,s illnesses. ...
... Operating Officer and Executive Vice President of WakeMed Health ... recipient of the first annual Healthcare ... for Professionals in Infection Control and Epidemiology (APIC). The ... has demonstrated significant support for infection prevention and control ...
... Mass., Oct. 16 Haemonetics Corporation (NYSE: HAE ) ... a pre-market press release and 10:00 am (EST) webcast. , ... will be available from November 2, 2009 after 1:00 pm ... Julie Fallon, Tel. (781) ...
... ... of American business, Dr. Philip Straka, a plastic surgeon in Houston , says he’s ... ... recession may be hitting a large number of economic sectors, but one area plastic surgeon ...
... Leading ... care of your health, particularly your heart, 365 days a year. , ... Fargo, ND (Vocus) October 16, 2009 -- ... has teamed up with Kaneka to travel the U.S. promoting heart health and their CoQ10 ...
Cached Medicine News:Health News:BCS Global Completes Polycom Telepresence VNOC (Video Network Operations Center) Provider Program 2Health News:BCS Global Completes Polycom Telepresence VNOC (Video Network Operations Center) Provider Program 3Health News:Survey Reveals Parents Are Eager to Learn about Alternative Medicine Options but Information is Lacking 2Health News:Survey Reveals Parents Are Eager to Learn about Alternative Medicine Options but Information is Lacking 3Health News:APIC Announces Winner of First Healthcare Administrator Award 2Health News:APIC Announces Winner of First Healthcare Administrator Award 3Health News:Houston Plastic Surgeon Seeing Growth in Aesthetic Enhancement Procedures Despite Rough Economy 2Health News:Houston Plastic Surgeon Seeing Growth in Aesthetic Enhancement Procedures Despite Rough Economy 3Health News:Swanson Health Products Joins Peggy Fleming in Promoting the Heart Health Benefits of Ubiquinol, a CoQ10 Dietary Supplement 2Health News:Swanson Health Products Joins Peggy Fleming in Promoting the Heart Health Benefits of Ubiquinol, a CoQ10 Dietary Supplement 3
The Guidant Fineline EZ leads with protective capsule are bipolar endocardial and designed for permanent implantation with pulse generators for cardiac pacing....
Tendril DX active-fixation leads allows for lower thresholds initially and during the lead maturation phase....
... The Model 6491 unipolar ... designed for temporary atrial and ... and after cardiac surgery. This ... downsized, making it the ideal ...
... Guidant Flextend lead is ... lead with an extendable/retractable ... helix design offers various ... permanent implantation in the ...
Medicine Products: